4.2 Article

Fluorescein-Based Type I Supramolecular Photosensitizer via Induction of Charge Separation by Self-Assembly

Journal

JACS AU
Volume 2, Issue 6, Pages 1472-1478

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jacsau.2c00243

Keywords

supramolecular assembly; fluorescein; type I photosensitizer; reactive oxygen species (ROS); charge separation

Funding

  1. Young Scientists (JSPS KAKENHI) [JP18K14189, 21K14601]
  2. AMED [JP19lm0203007, JP19lm0203014]
  3. Takeda Science Foundation
  4. Kowa Life Science Foundation
  5. Senri Life Science Foundation
  6. Kato Memorial Bioscience Foundation

Ask authors/readers for more resources

In this study, a strategy to form type I supramolecular photosensitizers (SPSs) utilizing charge-separated state induced by self-assembly was proposed. The switching mechanism from type II to I via self-assembly was clarified using photophysical and electrochemical analyses. The type I SPS demonstrated significant photodynamic therapy effects on cancer cells, providing a promising approach for the development of type I photosensitizers based on supramolecular assemblies.
Photosensitizers (PSs) are critical substances with considerable potential for use in non-invasive photomedicine. Type I PSs, which generate reactive radical species by electron transfer from the excited state induced via photoirradiation, attracted much attention because of their suitability for photodynamic therapy (PDT) irrespective of the oxygen concentration. However, most organic PSs are type II, which activates only oxygen, generating singlet oxygen (O-1(2)) via energy transfer from the triplet state. Here, we proposed a strategy to form type I supramolecular PSs (SPSs) utilizing the charge-separated state induced by self-assembly. This was demonstrated using a supramolecular assembly of fluorescein, which is a type II PS in the monomeric state; however, it changes to a type I SPS via self-assembly. The switching mechanism from type II to I via self-assembly was clarified using photophysical and electrochemical analyses, with the type I SPS exhibiting significant PDT effects on cancer cells. This study provides a promising approach for the development of type I PSs based on supramolecular assemblies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available